Table 2

sIL-2Rα levels in the mice treated with alemtuzumab alone and the combination of YM155 with alemtuzumab 6 months posttherapy

GroupssIL-2Rα (pg/mL) (6 mo posttherapy)
Alemtuzumab alone 4647 N.D. N.D. 
YM155 + alemtuzumab N.D. N.D. N.D. N.D. N.D. N.D. 
GroupssIL-2Rα (pg/mL) (6 mo posttherapy)
Alemtuzumab alone 4647 N.D. N.D. 
YM155 + alemtuzumab N.D. N.D. N.D. N.D. N.D. N.D. 

N.D., not detected.

or Create an Account

Close Modal
Close Modal